Effect of a Qigong Program in Non-Hodgkin Lymphoma Survivors
ATCQA members and certified instructors/practitioners can access the full content of this article on ATCQA website.
Sign in your ATCQA account and then click the link for "Study Materials".
July 26, 2022 - The treatment associated with non-Hodgkin lymphoma patients may cause adverse effects on their physical and psychological condition. As reported in the June 2022 issue of Journal of clinical medicine, Andalusia Research Plan, University of Granada and Arizona State University collaborated in a study to detect the response to an eight-week, 16-session, 60-min presential Qigong program in anxiety, depression and vagal nerve activity alongside a control group.
A randomized controlled clinical trial was managed. Anxiety levels were substantially decreased in the experimental group, with a large effect size. Depression levels had an improvement in the experimental group in contrast to the control group, reaching statistical significance. Heart Rate Variability unveiled significant results in terms of between-group differences, with a large effect size in the HRV Index, SDNN, and RMSSD in the time domain, and a medium effect size in the HF, LF, and LF/HF Ratio in the frequency domain, which were all bettered in the experimental group, after the Qigong program.
Qigong therapy can be an effective therapeutic activity in consonance with traditional medicine to improve psychological health and autonomic nervous system balance in non-Hodgkin lymphoma survivors.